Drug Delivery Strategies for the Treatment of Metabolic Diseases

被引:39
|
作者
Shi, Sanjun [1 ,2 ,3 ]
Kong, Na [1 ,2 ,3 ]
Feng, Chan [1 ,2 ,3 ]
Shajii, Aram [1 ,2 ,3 ]
Bejgrowicz, Claire [1 ,2 ,3 ]
Tao, Wei [1 ,2 ,3 ]
Forokhzad, Omid C. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
关键词
biomaterials; drug delivery; metabolic diseases; nanomedicine; LOOP INSULIN DELIVERY; ONE-POT SYNTHESIS; ORAL DELIVERY; POLYMERIC NANOPARTICLES; CONTROLLED-RELEASE; MODIFIED LEPTIN; GLUCOSE; OBESITY; INFLAMMATION; MECHANISMS;
D O I
10.1002/adhm.201801655
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Metabolic diseases occur when normal metabolic processes are disrupted in the human body, which can be congenital or acquired. The incidence of metabolic diseases worldwide has reached epidemic proportions. So far, various methods including systemic drug therapy and surgery are exploited to prevent and treat metabolic diseases. However, current pharmacotherapeutic options for treatment of these metabolic disorders remain limited and ineffective, especially reducing patient compliance to treatment. Therefore, it is desirable to exploit effective drug delivery approaches to effectively treat metabolic diseases and reduce side effects. This brief review summarizes novel delivery strategies including local, targeted, and oral drug delivery strategies, as well as intelligent stimulus-responsive drug delivery strategy, for the treatment of metabolic disorders including diabetes, obesity, and atherosclerosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases
    Mansor, Nur Izzati
    Nordin, Norshariza
    Mohamed, Farahidah
    Ling, King Hwa
    Rosli, Rozita
    Hassan, Zurina
    CURRENT DRUG DELIVERY, 2019, 16 (08) : 698 - 711
  • [32] A passive MEMS drug delivery pump for treatment of ocular diseases
    Lo, Ronalee
    Li, Po-Ying
    Saati, Saloomeh
    Agrawal, Rajat N.
    Humayun, Mark S.
    Meng, Ellis
    BIOMEDICAL MICRODEVICES, 2009, 11 (05) : 959 - 970
  • [33] Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
    Pala, Rajasekharreddy
    Anju, V. T.
    Dyavaiah, Madhu
    Busi, Siddhardha
    Nauli, Surya M.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 3741 - 3769
  • [34] A refillable microfabricated drug delivery device for treatment of ocular diseases
    Lo, Ronalee
    Li, Po-Ying
    Saati, Saloomeh
    Agrawal, Rajat
    Humayun, Mark S.
    Meng, Ellis
    LAB ON A CHIP, 2008, 8 (07) : 1027 - 1030
  • [35] Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
    Asil, Shima Masoudi
    Ahlawat, Jyoti
    Barroso, Gileydis Guillama
    Narayan, Mahesh
    BIOMATERIALS SCIENCE, 2020, 8 (15) : 4109 - 4128
  • [36] Novel Drug Delivery Methods and Approaches for the Treatment of Retinal Diseases
    Ham, Yeji
    Mehta, Hemal
    Kang-Mieler, Jennifer
    Mieler, William F.
    Chang, Andrew
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2023, 12 (04): : 402 - 413
  • [37] An innovative transdermal drug delivery device for the treatment of chronic diseases
    Bedoni, M.
    Donetti, E.
    Casella, M.
    Forvi, E.
    Gualerzi, A.
    Gramatica, F.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (12) : 1085 - 1086
  • [38] Hydrogels as drug delivery platforms for orthopedic diseases treatment: A review
    Ge, Bing
    Xie, Qinwen
    Wu, Di
    Xu, Jianfeng
    Jiao, Haolin
    Zhao, Dewei
    Li, Junlei
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 304
  • [40] Exosomes as potential drug delivery tools for treatment of cardiovascular diseases
    Xi-yong YU
    Song-pei LI
    中国药理学与毒理学杂志, 2018, 32 (04) : 327 - 328